- Home
- LSAK vs HUMA Comparison
LSAK vs HUMA Comparison
Compare LSAK & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LSAK
- HUMA
- Stock Information
- Founded
- LSAK 1997
- HUMA 2004
- Country
- LSAK South Africa
- HUMA United States
- Employees
- LSAK N/A
- HUMA N/A
- Industry
- LSAK Investment Bankers/Brokers/Service
- HUMA Biotechnology: Pharmaceutical Preparations
- Sector
- LSAK Finance
- HUMA Health Care
- Exchange
- LSAK Nasdaq
- HUMA Nasdaq
- Market Cap
- LSAK 408.0M
- HUMA 427.2M
- IPO Year
- LSAK N/A
- HUMA N/A
- Fundamental
- Price
- LSAK $4.55
- HUMA $1.44
- Analyst Decision
- LSAK
- HUMA Strong Buy
- Analyst Count
- LSAK 0
- HUMA 6
- Target Price
- LSAK N/A
- HUMA $14.60
- AVG Volume (30 Days)
- LSAK 35.6K
- HUMA 5.3M
- Earning Date
- LSAK 05-07-2025
- HUMA 05-09-2025
- Dividend Yield
- LSAK N/A
- HUMA N/A
- EPS Growth
- LSAK N/A
- HUMA N/A
- EPS
- LSAK N/A
- HUMA N/A
- Revenue
- LSAK $576,604,000.00
- HUMA N/A
- Revenue This Year
- LSAK $0.04
- HUMA N/A
- Revenue Next Year
- LSAK $1.74
- HUMA $1,178.15
- P/E Ratio
- LSAK N/A
- HUMA N/A
- Revenue Growth
- LSAK 5.39
- HUMA N/A
- 52 Week Low
- LSAK $3.83
- HUMA $1.15
- 52 Week High
- LSAK $5.60
- HUMA $9.97
- Technical
- Relative Strength Index (RSI)
- LSAK 46.89
- HUMA 35.89
- Support Level
- LSAK $4.39
- HUMA $1.35
- Resistance Level
- LSAK $4.60
- HUMA $1.54
- Average True Range (ATR)
- LSAK 0.22
- HUMA 0.16
- MACD
- LSAK 0.01
- HUMA 0.07
- Stochastic Oscillator
- LSAK 80.90
- HUMA 52.73
About LSAK Lesaka Technologies Inc.
Lesaka Technologies Inc provides payment solutions, transaction processing solutions, and financial technologies. The company operates two reportable segments: Merchant and Consumer. The company operates mainly within South Africa. The Merchant segment that derives majority revenue includes activities related to the provision of goods and services provided to corporate and other juristic entities. It earns fees from processing activities performed for its customers and revenue generated from the distribution of prepaid airtime. The Consumer segment includes activities related to the provision of financial services to customers, including bank accounts, loans, and insurance products. The firm charges monthly administration fees for all bank accounts.
About HUMA Humacyte Inc.
Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions.